vs
HomeTrust Bancshares, Inc.（HTB）与IRONWOOD PHARMACEUTICALS INC（IRWD）财务数据对比。点击上方公司名可切换其他公司
HomeTrust Bancshares, Inc.的季度营收约是IRONWOOD PHARMACEUTICALS INC的1.1倍（$53.6M vs $47.7M），HomeTrust Bancshares, Inc.同比增速更快（3.7% vs -47.3%），IRONWOOD PHARMACEUTICALS INC自由现金流更多（$74.6M vs $45.3M），过去两年HomeTrust Bancshares, Inc.的营收复合增速更高（3.5% vs -20.2%）
HomeTrust Bancshares, Inc.是总部位于美国北卡罗来纳州阿什维尔的银行控股公司，总资产达43亿美元，在北卡、南卡、佐治亚和田纳西州共设有33家网点，旗下拥有HomeTrust银行、Tryon联邦银行等七家社区银行。
Ironwood制药公司是一家上市制药企业，其前身为Microbia公司，专注于制药领域相关业务研发与运营，面向市场开发各类创新医药产品，满足未被充分满足的临床医疗需求。
HTB vs IRWD — 直观对比
营收规模更大
HTB
是对方的1.1倍
$47.7M
营收增速更快
HTB
高出51.0%
-47.3%
自由现金流更多
IRWD
多$29.3M
$45.3M
两年增速更快
HTB
近两年复合增速
-20.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $53.6M | $47.7M |
| 净利润 | — | $-2.3M |
| 毛利率 | — | — |
| 营业利润率 | 37.0% | 14.3% |
| 净利率 | — | -4.8% |
| 营收同比 | 3.7% | -47.3% |
| 净利润同比 | — | -200.9% |
| 每股收益（稀释后） | $0.93 | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HTBIRWD
| Q4 25 | $53.6M | $47.7M | ||
| Q3 25 | $54.1M | $122.1M | ||
| Q2 25 | $54.4M | $85.2M | ||
| Q1 25 | $50.9M | $41.1M | ||
| Q4 24 | $51.7M | $90.5M | ||
| Q3 24 | $50.6M | $91.6M | ||
| Q2 24 | $50.6M | $94.4M | ||
| Q1 24 | $50.0M | $74.9M |
净利润HTBIRWD
| Q4 25 | — | $-2.3M | ||
| Q3 25 | $16.5M | $40.1M | ||
| Q2 25 | $17.2M | $23.6M | ||
| Q1 25 | $14.5M | $-37.4M | ||
| Q4 24 | — | $2.3M | ||
| Q3 24 | $13.1M | $3.6M | ||
| Q2 24 | $12.4M | $-860.0K | ||
| Q1 24 | $15.1M | $-4.2M |
营业利润率HTBIRWD
| Q4 25 | 37.0% | 14.3% | ||
| Q3 25 | 38.5% | 61.8% | ||
| Q2 25 | 40.1% | 53.2% | ||
| Q1 25 | 36.2% | -70.7% | ||
| Q4 24 | 35.4% | 34.8% | ||
| Q3 24 | 33.2% | 28.0% | ||
| Q2 24 | 31.3% | 26.5% | ||
| Q1 24 | 38.0% | 14.7% |
净利率HTBIRWD
| Q4 25 | — | -4.8% | ||
| Q3 25 | 30.5% | 32.8% | ||
| Q2 25 | 31.6% | 27.7% | ||
| Q1 25 | 28.5% | -90.9% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | 25.9% | 4.0% | ||
| Q2 24 | 24.6% | -0.9% | ||
| Q1 24 | 30.1% | -5.6% |
每股收益（稀释后）HTBIRWD
| Q4 25 | $0.93 | $0.01 | ||
| Q3 25 | $0.95 | $0.23 | ||
| Q2 25 | $1.00 | $0.14 | ||
| Q1 25 | $0.84 | $-0.23 | ||
| Q4 24 | $0.83 | $0.03 | ||
| Q3 24 | $0.76 | $0.02 | ||
| Q2 24 | $0.73 | $-0.01 | ||
| Q1 24 | $0.88 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $324.7M | $215.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $600.7M | $-261.8M |
| 总资产 | $4.5B | $396.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资HTBIRWD
| Q4 25 | $324.7M | $215.5M | ||
| Q3 25 | $315.8M | $140.4M | ||
| Q2 25 | $297.2M | $92.9M | ||
| Q1 25 | $299.8M | $108.5M | ||
| Q4 24 | $279.2M | $88.6M | ||
| Q3 24 | $293.5M | $88.2M | ||
| Q2 24 | $294.2M | $105.5M | ||
| Q1 24 | $380.5M | $121.5M |
总债务HTBIRWD
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
股东权益HTBIRWD
| Q4 25 | $600.7M | $-261.8M | ||
| Q3 25 | $595.8M | $-264.2M | ||
| Q2 25 | $579.3M | $-308.2M | ||
| Q1 25 | $565.4M | $-334.1M | ||
| Q4 24 | $551.8M | $-301.3M | ||
| Q3 24 | $540.0M | $-311.3M | ||
| Q2 24 | $523.6M | $-321.7M | ||
| Q1 24 | $513.2M | $-330.5M |
总资产HTBIRWD
| Q4 25 | $4.5B | $396.9M | ||
| Q3 25 | $4.6B | $396.1M | ||
| Q2 25 | $4.6B | $342.9M | ||
| Q1 25 | $4.6B | $327.2M | ||
| Q4 24 | $4.6B | $350.9M | ||
| Q3 24 | $4.6B | $389.5M | ||
| Q2 24 | $4.7B | $395.6M | ||
| Q1 24 | $4.7B | $438.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $49.5M | $74.6M |
| 自由现金流经营现金流 - 资本支出 | $45.3M | $74.6M |
| 自由现金流率自由现金流/营收 | 84.5% | 156.3% |
| 资本支出强度资本支出/营收 | 7.8% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $93.8M | $127.0M |
8季度趋势，按日历期对齐
经营现金流HTBIRWD
| Q4 25 | $49.5M | $74.6M | ||
| Q3 25 | $-11.3M | $47.6M | ||
| Q2 25 | $-8.8M | $-15.1M | ||
| Q1 25 | $71.7M | $20.0M | ||
| Q4 24 | $45.4M | $15.2M | ||
| Q3 24 | $43.8M | $9.9M | ||
| Q2 24 | $5.9M | $33.5M | ||
| Q1 24 | $-9.0M | $45.0M |
自由现金流HTBIRWD
| Q4 25 | $45.3M | $74.6M | ||
| Q3 25 | $-12.0M | $47.6M | ||
| Q2 25 | $-10.2M | $-15.1M | ||
| Q1 25 | $70.7M | $19.9M | ||
| Q4 24 | $42.4M | — | ||
| Q3 24 | $43.1M | $9.9M | ||
| Q2 24 | $5.7M | $33.4M | ||
| Q1 24 | $-9.6M | $44.9M |
自由现金流率HTBIRWD
| Q4 25 | 84.5% | 156.3% | ||
| Q3 25 | -22.2% | 39.0% | ||
| Q2 25 | -18.7% | -17.7% | ||
| Q1 25 | 138.7% | 48.4% | ||
| Q4 24 | 82.0% | — | ||
| Q3 24 | 85.1% | 10.8% | ||
| Q2 24 | 11.2% | 35.4% | ||
| Q1 24 | -19.2% | 60.0% |
资本支出强度HTBIRWD
| Q4 25 | 7.8% | 0.0% | ||
| Q3 25 | 1.4% | 0.0% | ||
| Q2 25 | 2.5% | 0.0% | ||
| Q1 25 | 2.0% | 0.1% | ||
| Q4 24 | 5.9% | 0.0% | ||
| Q3 24 | 1.3% | 0.0% | ||
| Q2 24 | 0.5% | 0.1% | ||
| Q1 24 | 1.1% | 0.1% |
现金转化率HTBIRWD
| Q4 25 | — | — | ||
| Q3 25 | -0.68× | 1.19× | ||
| Q2 25 | -0.51× | -0.64× | ||
| Q1 25 | 4.93× | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | 3.34× | 2.71× | ||
| Q2 24 | 0.48× | — | ||
| Q1 24 | -0.60× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
